Published: 18 March 2021
HSE Drugs.ie in collaboration with the Health Research Board and the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) are asking adults in Ireland who use drugs to complete this survey to help shape the future of drug policies and interventions in Europe.
The voluntary, anonymous survey will run in over 30 countries and 29 languages for a 6 week period until the end of April 2021.
Web-based surveys have the benefit of reaching people who use drugs directly and provide new data rapidly to help identify emerging trends.
The survey will be promoted on the Drugs.ie Twitter feed and Drugs.ie Facebook page, by press release, paid social and media advertising and stakeholder engagement. Please share this information through channels and services relevant to people who use drugs in Ireland.
Targeted at people, aged 18 and over, who have used drugs in the last 12 months, the survey aims to improve understanding of patterns of drug use and the diverse user groups in Ireland. The survey is structured in modules on socio-demographics, drug-using patterns, access to treatment, access to drugs quantities purchased and prices paid and how COVID-19 has affected patterns of drug use.
Watch - Why a European Web Survey on Drugs?
Dr Eamon Keenan, National Clinical Lead, HSE Addiction Services said:
“We are generally well informed about people who attend addiction services but this is, of course, just part of the picture of drug use in Ireland as there are many groups who may never present to the current structures. What this survey will give us is a chance to learn about patterns, trends and emerging needs that will help to create interventions and harm reduction supports into the future.
The results of this survey will help us to form a picture of drug use in Ireland. Under the National Drugs Strategy, we are reviewing a range of ways to help us understand drug use such as drug checking services, waste water epidemiology, syringe analysis, hospital data and web surveys to improve harm reduction and risk communications.”